DEAR GOOGLE: I would be glad if you could please approve my site on Adsense as I link to the sources and I do a great deal of machine sorcery to rank, summarize and extract metadata from articles. Saying I infringe on copyright is the same as saying Google or Yahoo News are not legit. Thank you for reading.
[I have added the ad code to all pages, sorry for forgetting such an important thing]
this page has been updated 1 week ago

Hiv Prevention

In a major breakthrough in the fight against new HIV transmissions, a British pharmaceutical company...

https://en.wikipedia.org/wiki/Prevention_of_HIV/AIDS


News

PrEP injection every two months proves more effective than daily Truvada - Metro Weekly

In a major breakthrough in the fight against new HIV transmissions, a British pharmaceutical company...

discovered 1 week ago on Metro Weekly

Medical Officer (Physician) job with USAJobs | 41036657

Your application may not receive full consideration if you do not follow the instructions as outlined. This announcement is for the recruitment of four medical officer positions, located at ...

discovered 1 week ago on Washington Post

Berger Montague Class action lawsuit: Big Pharma firm Gilead Sciences sent envelopes marking...

PHILADELPHIA, May 22, 2020 /PRNewswire/ -- An Alabama man was mortified when an envelope for him with the return address HIV Prevention Team in bold red ...

discovered 1 week ago on WFMZ Eastern Pennsylvania and Western New Jersey

Bay Area’s Gilead sent envelopes revealing patients were on HIV drugs, lawsuit claims

Two men, from Alabama and Indiana, said in the suit that they were among hundreds of patients taking...

discovered 1 week ago on San Jose Mercury News

Global HIV Prevention Study Ends Early After Injectable Cabotegravir Shows High Efficacy

Today ViiV Healthcare announced the interim analysis of the HIV Prevention Trials Network (HPTN) 083 study evaluating the safety and efficacy of investigational ...

discovered 1 week ago on Stamford Advocate

GlaxoSmithKline, Pfizer, and Shionogi's HIV Prevention Candidate Outperforms Gilead's Truvada

People who took cabotegravir had an HIV incidence rate of 0.38%, compared...

discovered 1 week ago on Motley Fool

Exciting new results from long-acting PrEP study show it to be effective in preventing HIV...

The HIV Prevention Trials Network (HPTN 083) study on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for ...

discovered 1 week ago on World Health Organization

HIV drug patients’ privacy violated by Gilead, lawsuit claims

A drug company may have violated the privacy of thousands of people who are taking a medicine to...

discovered 1 week ago on The Idaho Statesman


trendingNow

trendingYesterday

trending1week

Help and support - Sitemap - Go to top